Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
COGT
COGT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
COGT News
Bezuclastinib Combination Shows Significant Benefit in GIST Patients
23h ago
Newsfilter
Cogent Biosciences Set for Dual Product Launches
2d ago
seekingalpha
FDA Accepts Bezuclastinib NDA with Priority Review
2d ago
Newsfilter
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Cogent Biosciences Presents Pivotal Data at EHA Congress
May 12 2026
Newsfilter
Major Wall Street Rating Updates
May 05 2026
CNBC
Cogent Biosciences Reports Q1 Net Loss of $97.4 Million
May 05 2026
seekingalpha
Cogent Biosciences Completes NDA Submission for Bezuclastinib
Apr 02 2026
NASDAQ.COM
Cogent Biosciences Submits New Drug Application
Apr 01 2026
NASDAQ.COM
RTW Investments Increases Stake in Cogent Biosciences Significantly
Mar 22 2026
Fool
RTW Investments Increases Stake in Cogent Biosciences
Mar 22 2026
NASDAQ.COM
RTW Investments Increases Stake in Cogent Biosciences by $116 Million
Mar 22 2026
Yahoo Finance
Kynam Capital Reduces Stake in Cogent Biosciences by $48.38 Million
Mar 21 2026
Fool
Kynam Capital Reduces Stake in Cogent Biosciences
Mar 21 2026
NASDAQ.COM
Kynam Capital Management Cuts Viridian Stake by Over $81 Million
Mar 21 2026
Yahoo Finance
Kynam Capital Reduces Stake in Cogent Biosciences by $48 Million
Mar 21 2026
Yahoo Finance
Show More News
